Abstract
Using gene expression and proteomic studies, Toll-like receptor 2 has been found to play a role in epidermal hyperkeratosis and the development of congenital ichthyosis. Downstream signalling involving GATA-3 reveals potential novel drug targets for congenital ichthyosis. Further studies of ichthyosis subtypes will provide more precise strategies for targeted therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
